Keyword: Boehringer Ingelheim
Chemistry & Life Sciences
03.02.2016
- A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...
News
12.01.2016
- Globally, mergers and acquisitions at a value of USD 372 billion were recorded in the chemical and pharmaceutical sector in 2015. This amounts to an increase of 74% compared with...
News
23.12.2015
- Bayer is likely to seek a major life sciences M&A deal in the next few years, banking sources have told the news agency Reuters. The German group’s absence from a recent wave of...
News
16.12.2015
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of...
News
11.12.2015
- An Indian court has unexpectedly sided with Swiss drugmaker Roche in a long-running patent dispute with Indian generics giant Cipla. A two-judge panel for the Delhi High Court...
News
17.08.2015
- German pharmaceutical company Boehringer Ingelheim has formed a three-year collaboration with Circuit Therapeutics to develop new medicines to treat obesity and associated diseases...
News
07.08.2015
- Boehringer Ingelheim, the German drugmaker, has sold its US generics business for $2.7 billion to London-based Jordanian-British owned Hikima Pharmaceuticals. At the same time, it...
News
01.06.2015
- The US Food and Drug Administration (FDA) has approved German drugmaker Boehringer Ingelheim's Stiolto Respimat (tiotropium bromide and olodaterol) once-a-day inhalation spray for...
